Back to results
US 9,541,556 B2Granted
Method and apparatus for providing glycemic control
AssigneeAbbott Diabetes Care Inc.
InventorsMarc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
Life of this patent
Estimating the term…
Abstract
Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided.
Claims20
A method implemented using one or more processors, comprising:
- determining, with one or more processors, a correlation between a mean glucose value information and an HbA1C level associated with a subject;
- determining, with the one or more processors, a rate of glycation of the subject based at least in part on the determined correlation between the mean glucose value information and the HbA1C level;
- applying, with the one or more processors, one or more subject specific parameters to the determined correlation between the mean glucose value information and the HbA1C level;
- determining, with the one or more processors, a target HbA1C level based on determining the rate of glycation of the subject and applying the one or more subject specific parameters to the determined correlation;
- and
- controlling, with the one or more processors, administration of therapy based on the determined target HbA1C level;
- wherein the one or more subject specific parameters includes an age of the subject, an activity level of the subject, a medication intake information of the subject, or a living condition of the subject.
4 more elements
An apparatus, comprising:
- one or more processors;
- and
- a memory for storing instructions which, when executed by the one or more processors, cause the one or more processors to determine a correlation between a mean glucose value information and an HbA1C level associated with a subject, to determine a rate of glycation of the subject based at least in part on the determined correlation between the received mean glucose value information and the HbA1C level, to apply one or more subject specific parameters to the determined correlation between the mean glucose value information and the HbA1C level, to determine a target HbA1C level based on determining the rate of glycation of the subject and applying the one or more subject specific parameters to the determined correlation, and to control administration of therapy based on the determined target HbA1C level, wherein the one or more subject specific parameters includes an age of the subject, an activity level of the subject, a medication intake information of the subject, or a living condition of the subject.
Dependencies are inferred from the claim text.